美国呼吸器和麻醉面罩市场规模、份额和趋势分析报告：按面罩类型、应用和细分市场预测，2025-2030 年

美国人工呼吸和麻醉面罩市场规模与趋势

预计 2024 年美国呼吸和麻醉面罩市场规模将达到 5.527 亿美元，2025 年至 2030 年的复合年增长率为 4.7%。

这种增长归因于呼吸系统疾病发生率的上升、技术的发展、外科手术数量的增加、人口增长（尤其是老年人口）、COVID-19 大流行的影响、医疗支出的增加以及政策支持。

慢性阻塞性肺病 (COPD)、气喘和肺炎等慢性呼吸系统疾病的盛行率不断上升，将推动市场成长。根据美国疾病管制与预防中心 (CDC) 2024 年 6 月的一份报告，约有 600 万美国成年人患有 COPD，COPD 是美国十大死因之一，这为医疗保健提供者和製造商投资呼吸照护解决方案创造了巨大的机会。此外，成人和儿童对长期居家照护和肺部疾病急性治疗的需求不断增长，也推动了市场需求的成长。

科技的进步使得呼吸和麻醉面罩更加易于使用且更有效率。诸如抛弃式整合监控系统、改进的面罩设计（可提高患者舒适度）以及增强的安全性能等特性，正吸引医疗保健提供者选择这些产品。此外，随着对优质呼吸照护解决方案的需求不断增长，製造商正在加大研发投入，以打造创新产品，满足医疗保健专业人员不断变化的需求。呼吸和麻醉面罩市场注重患者的舒适度、安全性和有效性，未来几年将迎来显着成长。

新冠疫情对美国呼吸和麻醉面罩市场造成了重大衝击，由于严重呼吸系统併发症的发生率高，呼吸支援设备的需求激增。医院和急诊室面临人工呼吸器及相关耗材（包括口罩）的严重短缺，促使其迅速扩大生产规模并获得美国食品药物管理局（FDA）的紧急使用授权。这场危机加速了一次性口罩的普及，以降低交叉污染的风险，并刺激了非侵入性呼吸技术的创新。此外，供应链中断和原材料短缺暴露了脆弱性，导致疫情后国内生产力度加大，并采取了囤货策略。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

• 市场体系展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会分析
  • 市场问题分析
• 商业环境分析
  • 波特五力分析
  • PESTLE分析
  • 定价分析
  • COVID-19的影响

第四章。美国呼吸器和麻醉面罩市场类型、估计和趋势分析

• 细分仪表板
• 美国呼吸器与麻醉面罩市场：类型变化分析，百万美元，2024 年与 2030 年
• 一次性口罩
• 可重复使用的口罩

第五章美国呼吸器和麻醉面罩市场的应用、预测和趋势分析

• 细分仪表板
• 美国呼吸器和麻醉面罩市场：2024 年和 2030 年应用趋势分析
• 手术室
• 加护病房
• 急诊室
• 居家医疗
• ASC

第六章 竞争态势

• 参与者概览
• 2024年企业市场地位/份额分析
• 公司分类
• 公司简介/上市公司
  • Medtronic
  • BD（Becton, Dickinson and Company）
  • ResMed
  • Vyaire Medical, Inc.
  • Dragerwerk AG & Co. KGaA
  • Koninklijke Philips NV
  • Nihon Kohden Corporation
  • Hamilton Medical
  • IBM
  • Ambu A/S
  • Cardinal Health

U.S. Artificial Ventilation And Anesthesia Masks Market Size & Trends:

The U.S. artificial ventilation and anesthesia masks market size was estimated at USD 552.7 million in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030. The growth can be attributed to the rising incidences of respiratory diseases, development in technology, rising number of surgeries, population growth, especially of the geriatric people, effects of the covid-19 pandemic, increased healthcare spending, and support in the policies.

The rising prevalence of chronic respiratory diseases such as COPD, asthma, and pneumonia will drive market growth. According to the CDC report of June 2024, around 6 million adults in the U.S. have COPD, and it is one of the top 10 causes of death in the U.S., presenting a significant opportunity for healthcare providers and manufacturers to invest in respiratory care solutions. The increasing demand for long-term home care and emergency treatment for lung diseases in adults and children will also contribute to market demand.

Advancements in technology have led to the development of more user-friendly and efficient artificial ventilation and anesthesia masks. Features such as integrated monitoring systems for disposables, improved mask designs for enhanced patient comfort, and enhanced safety features are attracting healthcare providers to these products. Moreover, as the demand for high-quality respiratory care solutions increases, manufacturers are investing in research and development to create innovative products that meet the evolving needs of healthcare professionals. With a focus on patient comfort, safety, and efficacy, the artificial ventilation and anesthesia masks market is poised for significant growth in the coming years.

The COVID-19 pandemic greatly impacted the U.S. artificial ventilation and anesthesia masks market, driving a surge in demand for respiratory support equipment due to the high incidence of severe respiratory complications. Hospitals and emergency departments faced acute shortages of ventilators and associated consumables, including masks, prompting rapid production scale-ups and emergency use authorizations by the FDA. The crisis accelerated the adoption of single-use and disposable masks to reduce cross-contamination risks and spurred innovations in non-invasive ventilation technologies. Additionally, supply chain disruptions and raw material shortages exposed vulnerabilities, leading to increased domestic manufacturing initiatives and stockpiling strategies post-pandemic.

U.S. Artificial Ventilation And Anesthesia Masks Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. artificial ventilation and anesthesia masks market report based on mask type and application:

• Mask Type Outlook (Revenue, USD Million, 2018 - 2030)
• Disposable Masks
• Reusable Masks
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Operating Rooms
• ICU
• Emergency Rooms
• Home Care
• ASCs

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing number of surgical procedures across hospitals and ambulatory centers
    • 3.2.1.2. Growing prevalence of respiratory disorders
    • 3.2.1.3. Technological advancements in mask materials, ergonomics, and integration with monitoring systems are enhancing product safety and comfort.
    • 3.2.1.4. Increased focus on patient safety and infection control
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Availability of alternative solutions
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape
  • 3.3.3. Pricing Analysis
  • 3.3.4. Impact of COVID 19

Chapter 4. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Movement Analysis, USD Million, 2024 & 2030
• 4.3. Disposable Masks
  • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Reusable Masks
  • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Movement Analysis, 2024 & 2030
• 5.3. Operating Rooms
  • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. ICU
  • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Emergency Rooms
  • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Homecare
  • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. ASCs
  • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position/Share Analysis, 2024
• 6.3. Company Categorization
• 6.4. Company Profiles/Listing
  • 6.4.1. Medtronic
    • 6.4.1.1. Overview
    • 6.4.1.2. Financial performance
    • 6.4.1.3. Product benchmarking
    • 6.4.1.4. Strategic initiatives
  • 6.4.2. BD (Becton, Dickinson and Company)
    • 6.4.2.1. Overview
    • 6.4.2.2. Financial performance
    • 6.4.2.3. Product benchmarking
    • 6.4.2.4. Strategic initiatives
  • 6.4.3. ResMed
    • 6.4.3.1. Overview
    • 6.4.3.2. Financial performance
    • 6.4.3.3. Product benchmarking
    • 6.4.3.4. Strategic initiatives
  • 6.4.4. Vyaire Medical, Inc.
    • 6.4.4.1. Overview
    • 6.4.4.2. Financial performance
    • 6.4.4.3. Product benchmarking
    • 6.4.4.4. Strategic initiatives
  • 6.4.5. Dragerwerk AG & Co. KGaA
    • 6.4.5.1. Overview
    • 6.4.5.2. Financial performance
    • 6.4.5.3. Product benchmarking
    • 6.4.5.4. Strategic initiatives
  • 6.4.6. Koninklijke Philips N.V.
    • 6.4.6.1. Overview
    • 6.4.6.2. Financial performance
    • 6.4.6.3. Product benchmarking
    • 6.4.6.4. Strategic initiatives
  • 6.4.7. Nihon Kohden Corporation
    • 6.4.7.1. Overview
    • 6.4.7.2. Financial performance
    • 6.4.7.3. Product benchmarking
    • 6.4.7.4. Strategic initiatives
  • 6.4.8. Hamilton Medical
    • 6.4.8.1. Overview
    • 6.4.8.2. Financial performance
    • 6.4.8.3. Product benchmarking
    • 6.4.8.4. Strategic initiatives
  • 6.4.9. IBM
    • 6.4.9.1. Overview
    • 6.4.9.2. Financial performance
    • 6.4.9.3. Product benchmarking
    • 6.4.9.4. Strategic initiatives
  • 6.4.10. Ambu A/S
    • 6.4.10.1. Overview
    • 6.4.10.2. Financial performance
    • 6.4.10.3. Product benchmarking
    • 6.4.10.4. Strategic initiatives
  • 6.4.11. Cardinal Health
    • 6.4.11.1. Overview
    • 6.4.11.2. Financial performance
    • 6.4.11.3. Product benchmarking
    • 6.4.11.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. artificial ventilation and anesthesia masks market, Type, 2018 - 2030 (USD Million)
• Table 4 U.S. artificial ventilation and anesthesia masks market, by Application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Market segmentation
• Fig. 8 Market snapshot
• Fig. 9 Segment snapshot
• Fig. 10 Competitive landscape snapshot
• Fig. 11 Market trends & outlook
• Fig. 12 Market driver relevance analysis (current & future impact)
• Fig. 13 Market restraint relevance analysis (current & future impact)
• Fig. 14 PESTLE analysis
• Fig. 15 Porter's five forces analysis
• Fig. 16 U.S. artificial ventilation and anesthesia masks market Type Outlook: Key Takeaways
• Fig. 17 U.S. artificial ventilation and anesthesia masks market: type movement analysis, 2018 & 2030
• Fig. 18 Disposable masks market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 19 Reusable masks market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 20 U.S. artificial ventilation and anesthesia masks market application outlook: Key takeaways
• Fig. 21 U.S. artificial ventilation and anesthesia masks market: application movement analysis, 2018 & 2030 (USD Million)
• Fig. 22 Operating Rooms market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 23 ICU market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 24 Emergency rooms market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 25 Home care market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 26 ASCs market estimates and forecasts 2018 - 2030 (USD Million)
• Fig. 27 Market Participant Categorization
• Fig. 28 Strategy mapping
• Fig. 29 Company market position analysis